A trial to assess metformin, alone vs in combination with linagliptin, in patients with type 2 diabetes who were previously treated with metformin but discontinued treatment due to gastrointestinal intolerance.

Trial Profile

A trial to assess metformin, alone vs in combination with linagliptin, in patients with type 2 diabetes who were previously treated with metformin but discontinued treatment due to gastrointestinal intolerance.

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Nov 2014

At a glance

  • Drugs Linagliptin (Primary) ; Metformin
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 22 Nov 2014 New trial record
    • 17 Sep 2014 Results presented at the 50th Annual Meeting of the European Association for the Study of Diabetes.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top